
Alternative Investments
Evergreen Funds Hit $534.6B: Redemption Crisis Nobody's Talking About
David Chen··15 min read

Alternative Investments
Frontier Bio Raises Capital for Lab-Grown Human Tissue: Investor Checklist for Biotech Reg CF
Jeff Barnes··11 min read

Alternative Investments
Alternative Credit Investment Strategies 2026: Why T. Rowe Price's $2B OFLEX Fund Signals the End of Equity-Only Portfolios
David Chen··17 min read
Alternative Investments
How to Use a Self-Directed IRA for Alternative Investments
Jeff Barnes··15 min read

Alternative Investments
Why T. Rowe Price's $1.2B OFLEX Fund Launch Signals Credit Markets Are Becoming the New PE Playbook
David Chen··14 min read

Alternative Investments
T. Rowe Price's $2B+ OFLEX Fund Launch: Why Credit Strategies Are Outpacing Equity in 2026
Jeff Barnes··12 min read

Alternative Investments
Fusion Energy's Path to Capital: How Deep Tech Gets Funded (Pranos Fusion Case Study)
Jeff Barnes··7 min read

Alternative Investments
Climate Tech & Clean Energy: The $2.8T Transition & Mega-Deals in 2025
Jeff Barnes··17 min read

Alternative Investments
Healthcare & Biotech: The $25.1B Market & Mega-Rounds in 2025
Jeff Barnes··16 min read

Alternative Investments
Cybersecurity: The $219B Investment Opportunity in 2026
Jeff Barnes··12 min read

Alternative Investments
T. Rowe Price's $1B+ OFLEX Fund Launch: Why Institutional Credit Funds Are Eating Venture Capital's Lunch in 2026
Jeff Barnes··11 min read

Alternative Investments
Why UK AIFMs Are Rushing to SEC Compliance: The Untapped Arbitrage in Cross-Border Alternative Fund Management
Jeff Barnes··17 min read